Navigating Prior Authorization for Imaging Studies: What's Changed and What Still Works in 2026

If you've spent any time in medical billing over the past few years, you already know that prior authorization for imaging studies has become one of the most frustrating pain points in the entire revenue cycle. And honestly? It's gotten more complicated, not less. MRI and CT authorizations in particular are consuming enormous amounts of staff time, and the denial rates aren't improving. But here's the thing — most of the imaging auth denials I see aren't happening because the study wasn't medically necessary. They're happening because of process breakdowns that are completely fixable. Let's talk about what's actually going on and what you can do about it.

Understanding Why Imaging Auths Are Getting Harder

Payers have quietly tightened their clinical criteria for advanced imaging over the past 18 months. Many commercial plans — and increasingly Medicare Advantage plans — now require stepped therapy documentation before approving an MRI. That means before you can get authorization for a lumbar spine MRI, for example, you may need to show that the patient tried and failed conservative treatment like physical therapy or chiropractic care for a specific number of weeks.

The challenge is that this information isn't always front-of-mind for the ordering physician, and it's rarely captured in a format that's easy to pull together quickly. So what happens? Your authorization team submits the request, it comes back denied for "insufficient clinical information," and now you're in the appeals queue.

A few other things that have shifted:

• Radiology benefit managers (RBMs) like Carelon (formerly AIM Specialty Health) and eviCore are now managing imaging benefits for an even broader swath of commercial and Medicare Advantage plans than they were two years ago. If you're not already tracking which of your major payers route imaging auth through an RBM, that's your first homework assignment.


• CPT code specificity matters more than ever. Submitting an auth request for a generic "MRI brain" without the appropriate laterality or contrast specifications is a quick path to delay or denial.


• Turnaround time expectations have shifted. Some payers have reduced their standard review windows, which means submitting an incomplete request doesn't just get denied — it gets denied faster.

Getting the Clinical Documentation Right the First Time

This is where most practices lose the battle before it even starts. The clinical documentation attached to an imaging auth request has to tell a story — and that story needs to match exactly what the payer's clinical criteria require.

Here's a practical approach that works: build condition-specific documentation checklists that map directly to the payer's guidelines. For example, if you're submitting a cervical spine MRI for a patient with neck pain and radiculopathy for a Blue Cross plan that routes through eviCore, you need:

• Symptom duration and onset documentation


• Neurological examination findings (or notation of their absence)


• Prior conservative treatment with dates and duration


• Any prior imaging and its results


• Clinical rationale for why the study will change management

Yes, building these checklists takes time upfront. But once they exist, your authorization staff can work through them systematically rather than hunting through the chart and hoping they grabbed everything relevant. Practices that do this consistently see their first-pass approval rates improve meaningfully — we're talking 15-25% in some cases.

One more thing on documentation: make sure you're including the treating physician's clinical notes, not just the order. The order tells the payer what is being requested. The notes tell them why — and that "why" is what gets you approved.

Managing Peer-to-Peer Reviews Without Losing Your Mind

Nobody loves peer-to-peer reviews, but they're one of the most effective tools you have for overturning initial denials on imaging studies. The key is speed and preparation.

Most payers give you a limited window to request a P2P — often 72 hours from the denial notice, sometimes less. If your workflow doesn't have a clear handoff process that gets that denial in front of the ordering physician same day, you're probably missing that window regularly.

When you do get to the P2P call:

• Brief the physician beforehand. A two-minute heads-up call or a summary note in the patient chart goes a long way. The physician shouldn't be walking into that conversation cold.


• Have the denial reason in hand. Know specifically which clinical criterion the payer said wasn't met. That's what the conversation needs to address.


• Document the outcome immediately. Whether the decision is overturned or upheld, get it in writing and update your auth tracking system right away.

Overturn rates for imaging P2P reviews are actually pretty decent — many practices see 40-60% of P2P reviews go their way when the physician is prepared and the call is timely. That's not a number to walk away from.

What the Appeals Process Actually Looks Like Now

When a P2P doesn't go your way, or when you've missed that window, you're into formal appeals — and this is where things can drag on. The good news is that appeal quality has improved significantly for practices that have invested in better tools and processes.

A well-written appeal for an imaging denial needs to:

• Directly cite the payer's own clinical criteria and explain how the patient's clinical picture meets them


• Reference peer-reviewed literature that supports medical necessity (relevant clinical guidelines from ACR, for example, carry weight)


• Be specific to this patient — not a generic template that reads like it was written for anyone

One thing worth knowing: AI-powered appeal letter generators have matured a lot in the past year or two. Some of these tools can pull relevant clinical criteria and literature and help your team draft a solid, patient-specific appeal in a fraction of the time it used to take. They're not a magic bullet, but for practices dealing with high imaging denial volumes, they're worth exploring.

External appeal rights are also something to keep top of mind. For fully insured commercial plans, patients have the right to an independent external review in most states, and the overturn rates there can be surprisingly favorable for imaging denials that were legitimately medically necessary.

Building a Smarter Tracking System

You cannot manage what you can't measure. If your team is tracking imaging auths in a spreadsheet (or worse, not tracking them systematically at all), you're flying blind.

At minimum, you want to be tracking: initial approval vs. denial rate by payer, denial reason codes, P2P request rate and outcome, appeal rate and outcome, and average days to resolution. Once you have that data, patterns emerge fast. Maybe one RBM is denying lumbar spine MRIs at twice the rate of another. Maybe one ordering physician's documentation consistently lacks the conservative treatment history that payers want to see. Those are fixable problems — but only if you can see them.

Moving Forward

Prior authorization for imaging isn't getting easier, but it is getting more manageable for practices that build systematic, well-documented processes. Start by auditing your current imaging denial reasons for the last 90 days — that alone will tell you where your biggest gaps are. Then work backwards: what documentation was missing, what criteria weren't addressed, and what could have been caught before submission?

The practices that are winning on imaging auth right now aren't necessarily bigger or better-staffed. They're more methodical. They've built their processes around payer criteria rather than hoping the clinical notes speak for themselves. And they've invested in getting their teams the information and tools they need to do this work well. That's all very much within reach — and it makes a real difference, both in approvals and in the staff sanity department.